Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 35 Genitourinary 11 Breast 11 Classical hematology 9 Thoracic 8 Plasma cell 8 Myeloid 7 Gynecologic 6 Tumor-Agnostic 4 Head & Neck 3 Dermatologic 3 Sarcoma 2 CNS 2 Other solid neoplasm 1 Other neoplasm 1 Other hematologic neoplasm 1 Other 1 Lymphoid 1

Conditions

Interventions

Exercise 27 Metformin 20 Surveys and Questionnaires 19 Methods 14 Educational Status 12 Early Intervention, Educational 11 Counseling 11 Tirzepatide 9 Standard of Care 9 Nutrition Assessment 9 Diet Therapy 9 Resistance Training 8 Radiotherapy 8 Diet 8 Interviews as Topic 7 Liraglutide 6 semaglutide 5 Radiation 5 Low-Level Light Therapy 5 Exenatide 5 Diet, Mediterranean 5 Dexamethasone 5 Cryotherapy 5 Caloric Restriction 5 Blood Specimen Collection 5 Bariatric Surgery 5 Vitamin D 4 Therapeutics 4 Sugars 4 Specimen Handling 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Aspirin × Other × Clear all

NCT02062255 2016-10-26

Impact of COX2 on Sera Biomarkers From Obese Subjects

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Completed

Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡